Compare A & CLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | A | CLS |
|---|---|---|
| Founded | 1999 | 1994 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Electrical Products |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.8B | 37.7B |
| IPO Year | 1999 | 1999 |
| Metric | A | CLS |
|---|---|---|
| Price | $131.20 | $355.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 15 |
| Target Price | $161.47 | ★ $404.13 |
| AVG Volume (30 Days) | 2.1M | ★ 2.1M |
| Earning Date | 05-27-2026 | 04-27-2026 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | 3.16 | ★ 98.34 |
| EPS | ★ 2.27 | 1.83 |
| Revenue | $4,472,000,000.00 | ★ $12,390,900,000.00 |
| Revenue This Year | $8.45 | $41.81 |
| Revenue Next Year | $6.13 | $39.95 |
| P/E Ratio | ★ $55.81 | $191.99 |
| Revenue Growth | 6.43 | ★ 28.46 |
| 52 Week Low | $108.35 | $144.27 |
| 52 Week High | $160.27 | $474.03 |
| Indicator | A | CLS |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 43.64 |
| Support Level | $120.88 | $331.35 |
| Resistance Level | $140.68 | $424.57 |
| Average True Range (ATR) | 3.48 | 24.34 |
| MACD | -0.92 | -5.16 |
| Stochastic Oscillator | 44.89 | 12.03 |
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.